Literature DB >> 30281072

Preoperative Oral Antibiotic Prophylaxis Reduces Surgical Site Infections After Elective Colorectal Surgery: Results From a Before-After Study.

Tessa Mulder1, Rogier M P H Crolla2, Marjolein F Q Kluytmans-van den Bergh1,3,4, Maaike S M van Mourik5, Jannie Romme4, George P van der Schelling2, Jan A J W Kluytmans1,4,6.   

Abstract

BACKGROUND: Surgical site infections (SSIs) are common complications after colorectal procedures and remain an important source of morbidity and costs. Preoperative oral antibiotic prophylaxis is a potential infection control strategy, but its effectiveness without simultaneous use of mechanical bowel preparation (MBP) is unclear. In this study, we aimed to determine whether preoperative oral antibiotics reduce the risk of deep SSIs in elective colorectal surgery.
METHODS: We performed a before-after analysis in a teaching hospital in the Netherlands. Patients who underwent surgery between January 2012 and December 2015 were included. On 1 January 2013, oral antibiotic prophylaxis with tobramycin and colistin was implemented as standard of care prior to colorectal surgery. The year before implementation was used as the control period. The primary outcome was a composite of deep SSI and/or mortality within 30 days after surgery.
RESULTS: Of the 1410 patients, 352 underwent colorectal surgery in the control period and 1058 in the period after implementation of the antibiotic prophylaxis. We observed a decrease in incidence of the primary endpoint of 6.2% after prophylaxis implementation. When adjusted for confounders, the risk ratio for development of the primary outcome was 0.58 (95% confidence interval, 0.40-0.79). Other findings included a decreased risk of anastomotic leakage and a reduction in the length of postoperative stay.
CONCLUSIONS: Preoperative oral antibiotic prophylaxis prior to colorectal surgery is associated with a significant decrease in SSI and/or mortality in a setting without MBP. Preoperative oral antibiotics can therefore be considered without MBP for patients who undergo colorectal surgery.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  colistin; colorectal surgery; preoperative oral antibiotic prophylaxis; surgical site infection; tobramycin

Year:  2019        PMID: 30281072     DOI: 10.1093/cid/ciy839

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  Oral antibiotics prior to colorectal surgery: Do they have to be combined with mechanical bowel preparation?

Authors:  Tessa Mulder; Jan A J W Kluytmans
Journal:  Infect Control Hosp Epidemiol       Date:  2019-06-14       Impact factor: 3.254

2.  Incision pressing, a simple and effective intervention to reduce colorectal surgical site infection: A propensity score-matched study.

Authors:  Yugang Jiang; Hongyuan Chen; Guotao Liu; Meifeng Liu; Meng Kong; Hongguang Sheng
Journal:  Front Surg       Date:  2022-07-26

3.  Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: results of a multicenter randomized placebo-controlled clinical trial.

Authors:  Tessa Mulder; Marjolein Kluytmans-van den Bergh; Bart Vlaminckx; Daphne Roos; Anne Marie de Smet; Robert de Vos Tot Nederveen Cappel; Paul Verheijen; Alexandra Brandt; Anke Smits; Eric van der Vorm; Erik Bathoorn; Boudewijn van Etten; Jacobien Veenemans; Annemarie Weersink; Margreet Vos; Nils van 't Veer; Stavros Nikolakopoulos; Marc Bonten; Jan Kluytmans
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-15       Impact factor: 4.887

4.  Mechanical plus oral bowel preparation with paromomycin and metronidazole reduces infectious complications in elective colorectal surgery: a matched case-control study.

Authors:  Matthias Mehdorn; Christoph Lübbert; Iris F Chaberny; Ines Gockel; Boris Jansen-Winkeln
Journal:  Int J Colorectal Dis       Date:  2021-04-25       Impact factor: 2.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.